FDA Approves New Treatment for Alzheimer’s Disease | WNT

On: November 1, 2025

Tagged: New Drug, Alzheimer's Disease, FDA

BioGen’s “Aduhelm” is a monthly injection intended to slow cognitive decline in patients with early stages of the disease. The FDA granted the drug approval as a new clinical trial begins.

What I Wish I’d Known About Allergic Anaphylaxis

Researchers Unveil Surprising Flu Test That Works Before Symptoms Appear

New FDA Approved Treatment for Hyperhidrosis - SLUCare Health Watch

Previous Post: FDA Recalls 500K Bottles of Blood Pressure Drug Over Cancer Risk

Next Post: FDA Approves New Hormone-Free Drug to Treat Menopause

Resize text-+=

FDA Approves New Treatment for Alzheimer’s Disease | WNT

Related posts:

What I Wish I’d Known About Allergic Anaphylaxis

Researchers Unveil Surprising Flu Test That Works Before Symptoms Appear

New FDA Approved Treatment for Hyperhidrosis - SLUCare Health Watch